Related Experiment Video

Updated: May 31, 2026

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis
10:35

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis

Published on: January 30, 2020

Non-coding nucleotides and amino acids near the active site regulate peptide deformylase expression and inhibitor

Xiaofeng Bao1, Niseema D Pachikara1, Christopher B Oey1

  • 1Department of Physiology and Biophysics, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08854, USA.

Microbiology (Reading, England)
|July 2, 2011
PubMed

Insights

Hydroxamic-acid-based inhibitors target peptide deformylase (PDF) in Chlamydia trachomatis. Understanding chlamydial PDF (cPDF) gene regulation and enzyme mutations reveals mechanisms of resistance and therapeutic potential.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Chlamydia trachomatis is a prevalent human pathogen.
  • Hydroxamic-acid-based inhibitors show therapeutic potential against C. trachomatis.
  • The specific target and resistance mechanisms are not fully understood.

Purpose of the Study:

  • To identify the sole target of hydroxamic-acid-based inhibitors in C. trachomatis.
  • To elucidate molecular mechanisms controlling chlamydial PDF (cPDF) expression and inhibitor efficiency.
  • To investigate resistance mechanisms.

Main Methods:

  • Genome sequencing
  • Promoter analysis
  • Enzyme kinetics studies
  • Site-directed mutagenesis

Main Results:

  • Peptide deformylase (PDF) is the sole target of the inhibitors.
  • A σ⁶⁶-dependent promoter controls cPDF gene expression.
  • Promoter mutations confer resistance by increasing cPDF transcription.
  • Amino acid substitutions alter cPDF enzyme kinetics and stability.

Conclusions:

  • cPDF is the validated target for hydroxamic-acid-based inhibitors in C. trachomatis.
  • Understanding cPDF regulation and mutations is crucial for developing effective therapies.
  • This study provides insights into antimicrobial resistance mechanisms.

More Related Videos

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

Forward Genetic Approaches in Chlamydia trachomatis09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...